創薬インフォマティクスの世界市場、規模、シェア、動向、産業分析レポート：アプリケーション別、モード別、サービス別、エンドユーザー別、地域別 - 市場予測、2024年～2032年

Polaris Market Research社の最新調査によると、世界の創薬インフォマティクス市場規模は2032年までに81億3,256万米ドルに達する見込みです。本レポートでは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

人工知能との統合やクラウドコンピューティングなどの技術的進歩が、創薬インフォマティクス市場の成長を促進しています。テクノロジーを基盤とする複数の企業が、ヘルスケア業界の急増するニーズに対応するために創薬ソリューションを導入しています。ヘルスケアにおけるAIの応用は創薬プロセスに革命をもたらし、複雑な生物医学データの取り扱いをより巧みにします。そのため、革新的な技術アップグレードが創薬インフォマティクス市場の成長を後押ししています。

さらに、創薬プロセスを加速させるために企業が行っている多額の投資も、市場の成長を後押ししています。こうした投資は創薬インフォマティクスの能力を強化し、革新的な治療法への道を開いています。その結果、高度なインフォマティクスモデルと多額の資金的裏付けの組み合わせが医薬品開発を促進し、創薬インフォマティクス市場の成長を促しています。

業界プレイヤーの拡大・成長活動も、創薬インフォマティクスの発展を後押ししています。このような活動には、研究機関、学術機関、製薬会社との買収、提携、パートナーシップなどが含まれ、市場のイノベーションを促進しています。さらに、創薬インフォマティクス市場は競争が激しく、複数の世界企業や地域企業が市場の覇権を争っています。世界企業は、AI主導の洞察、データ分析、製薬研究に特化したクラウドベースのソリューションなど、革新的な製品を提供して市場を独占しています。

創薬インフォマティクス市場レポートハイライト

製薬企業による研究開発活動の活発化により、市場の創薬セグメントは今後数年間で大幅な成長が見込まれます。

2023年には、BLAST、FASTA、CLUSTALWなどの高度なプラットフォームが最新の創薬・薬剤開発を大幅に促進したため、シーケンス解析プラットフォームセグメントが収益面で市場を独占しました。これらのプラットフォームにより、研究者は膨大な量のゲノムデータを効率的に解析・解釈できるようになりました。

北米の創薬インフォマティクス市場は、堅調な製薬業界の存在により最大の売上シェアを占めています。

世界の創薬インフォマティクス企業が創薬と開発の主要プレーヤーとして中国への関心を高めていることが、中国の創薬インフォマティクス市場の成長を促進すると予想されます。

世界の主要市場プレーヤーは、Accenture, Agilent Technologies, Inc., Boehringer Ingelheim International GmbH, Certara, Charles River Laboratories, Chemaxon Ltd., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Illumina, Inc., Infosys Limited, Jubilant Biosys Ltd., Oracle, QIAGEN, Sapio Sciences, Selvitaです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の創薬インフォマティクス市場の洞察

• アプリケーションスナップショット
• 創薬インフォマティクス市場力学
  • 促進要因と機会
    • 業界プレーヤーが採用している重要な成長戦略が、創薬インフォマティクス市場の成長を牽引
    • 希少疾患向け製品の開発に向けた政府の取り組みが創薬インフォマティクス市場規模の拡大を牽引
  • 抑制要因と課題
    • データ品質の一貫性の欠如が創薬インフォマティクスの導入を妨げている
• PESTEL分析
• 創薬インフォマティクス市場のアプリケーション動向
• バリューチェーン分析
• COVID-19の影響分析

第5章 世界の創薬インフォマティクス市場：アプリケーション別

• 主な調査結果
• イントロダクション
• 創薬
• 医薬品開発

第6章 世界の創薬インフォマティクス市場：モード別

• 主な調査結果
• イントロダクション
• アウトソーシング
• インハウス

第7章 世界の創薬インフォマティクス市場：サービス別

• 主な調査結果
• イントロダクション
• 臨床試験データ管理
• ドッキング
• 分子モデリング
• シーケンス解析プラットフォーム
• その他

第8章 世界の創薬インフォマティクス市場：エンドユーザー別

• 主な調査結果
• イントロダクション
• バイオテクノロジー企業
• CRO
• 製薬企業
• その他

第9章 世界の創薬インフォマティクス市場：地域別

• 主な調査結果
• イントロダクション
  • 創薬インフォマティクス市場評価：地域別、2019-2032年
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋地域
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東・アフリカ
• ラテンアメリカ
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第11章 企業プロファイル

• Accenture
• Agilent Technologies, Inc.
• Boehringer Ingelheim International GmbH
• Certara
• Charles River Laboratories
• Chemaxon Ltd.
• Collaborative Drug Discovery Inc.
• Eurofins DiscoverX Products
• Illumina, Inc.
• Infosys Limited
• Jubilant Biosys Ltd.
• Oracle
• QIAGEN
• Sapio Sciences
• Selvita

List of Tables:

• Table 1 Global Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 2 Global Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 3 Global Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 4 Global Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 5 North America: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 6 North America: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 7 North America: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 8 North America: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 9 U.S.: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 10 U.S.: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 11 U.S.: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 12 U.S.: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 13 Canada: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 14 Canada: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 15 Canada: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 16 Canada: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 17 Europe: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 18 Europe: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 19 Europe: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 20 Europe: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 21 UK: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 22 UK: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 23 UK: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 24 UK: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 25 France: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 26 France: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 27 France: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 28 France: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 29 Germany: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 30 Germany: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 31 Germany: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 32 Germany: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 33 Italy: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 34 Italy: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 35 Italy: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 36 Italy: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 37 Spain: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 38 Spain: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 39 Spain: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 40 Spain: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 41 Netherlands: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 42 Netherlands: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 43 Netherlands: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 44 Netherlands: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 45 Russia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 46 Russia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 47 Russia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 48 Russia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 49 Rest of Europe: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 50 Rest of Europe: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 51 Rest of Europe: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 52 Rest of Europe: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 53 Asia Pacific: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 54 Asia Pacific: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 55 Asia Pacific: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 56 Asia Pacific: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 57 China: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 58 China: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 59 China: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 60 China: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 61 India: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 62 India: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 63 India: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 64 India: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 65 Malaysia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 66 Malaysia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 67 Malaysia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 68 Malaysia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 69 Japan: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 70 Japan: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 71 Japan: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 72 Japan: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 73 Indonesia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 74 Indonesia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 75 Indonesia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 76 Indonesia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 77 South Korea: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 78 South Korea: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 79 South Korea: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 80 South Korea: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 81 Australia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 82 Australia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 83 Australia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 84 Australia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 85 Rest of Asia Pacific: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 86 Rest of Asia Pacific: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 87 Rest of Asia Pacific: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 88 Rest of Asia Pacific: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 89 Middle East & Africa: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 90 Middle East & Africa: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 91 Middle East & Africa: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 92 Middle East & Africa: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 93 Saudi Arabia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 94 Saudi Arabia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 95 Saudi Arabia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 96 Saudi Arabia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 97 UAE: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 98 UAE: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 99 UAE: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 100 UAE: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 101 Israel: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 102 Israel: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 103 Israel: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 104 Israel: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 105 South Africa: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 106 South Africa: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 107 South Africa: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 108 South Africa: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 109 Rest of Middle East & Africa: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 110 Rest of Middle East & Africa: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 111 Rest of Middle East & Africa: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 112 Rest of Middle East & Africa: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 113 Latin America: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 114 Latin America: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 115 Latin America: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 116 Latin America: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 117 Mexico: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 118 Mexico: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 119 Mexico: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 120 Mexico: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 121 Brazil: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 122 Brazil: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 123 Brazil: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 124 Brazil: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 125 Argentina: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 126 Argentina: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 127 Argentina: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 128 Argentina: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• Table 129 Rest of Latin America: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• Table 130 Rest of Latin America: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• Table 131 Rest of Latin America: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• Table 132 Rest of Latin America: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)

List of Figures:

• Figure 1. Global Drug Discovery Informatics Market, 2019-2032 (USD Million)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Application
• Figure 7. Global Drug Discovery Informatics Market, by Application, 2023 & 2032 (USD Million)
• Figure 8. Market by Mode
• Figure 9. Global Drug Discovery Informatics Market, by Mode, 2023 & 2032 (USD Million)
• Figure 10. Market by Services
• Figure 11. Global Drug Discovery Informatics Market, by Services, 2023 & 2032 (USD Million)
• Figure 12. Market by End User
• Figure 13. Global Drug Discovery Informatics Market, by End User, 2023 & 2032 (USD Million)

The global drug discovery informatics market size is expected to reach USD 8,132.56 million by 2032, according to a new study by Polaris Market Research. The report "Global Drug Discovery Informatics Market Size, Share, Trends, Industry Analysis Report: Information By Application (Drug Discovery, Drug Development), By Mode, By Services, By End-User, and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Technological advancements such as integration with artificial intelligence and cloud computing are propelling the growth of the drug discovery informatics market. Several technology-based companies are introducing drug discovery solutions to meet the burgeoning needs of the healthcare industry. The application of AI in healthcare is revolutionizing the drug discovery process, making it more adept at handling the complexity of biomedical data. Therefore, innovative technological upgrades are propelling the growth of the drug discovery informatics market.

Moreover, the substantial investments made by companies to accelerate drug discovery processes are also fueling market growth. These investments have bolstered the capabilities of drug discovery informatics, paving the way for innovative therapeutics. Consequently, the combination of advanced informatics models with substantial financial backing is fostering drug development, thus stimulating the growth of the drug discovery informatics market.

The expansion and growth activities of industry players also fuel the development of drug discovery informatics. The activities include acquisitions, collaborations, and partnerships with research organizations, academic institutions, and pharmaceutical companies to drive innovation in the market. Moreover, the drug discovery informatics market is competitive, with several global and regional players vying for market dominance. Global players are dominating the market with innovative offerings that cover AI-driven insights, data analytics, and cloud-based solutions tailored specifically for pharmaceutical research.

Drug Discovery Informatics Market Report Highlights

The market's drug development segment is expected to experience substantial growth in the coming years due to the rising research and development activities by pharmaceutical companies.

In 2023, the sequence analysis platforms segment dominated the market in terms of revenue because advanced platforms such as BLAST, FASTA, and CLUSTALW significantly facilitated modern drug discovery and development. These platforms empowered researchers to analyze and interpret vast amounts of genomic data efficiently.

The North American drug discovery informatics market held the largest revenue share due to the presence of a robust pharmaceutical industry.

The growing interest of global drug discovery informatics companies in China as a key player in drug discovery and development is expected to drive the growth in the China drug discovery informatics market.

The global key market players are Accenture, Agilent Technologies, Inc., Boehringer Ingelheim International GmbH, Certara, Charles River Laboratories, Chemaxon Ltd., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Illumina, Inc., Infosys Limited, Jubilant Biosys Ltd., Oracle, QIAGEN, Sapio Sciences, and Selvita.

Polaris Market Research has segmented the drug discovery informatics market report based on application, mode, services, end-user, and region:

Drug Discovery Informatics, Application Outlook (Revenue - USD Million, 2019 - 2032)

• Drug Discovery
• Identification, Validation, & Assay Development Informatics
• Lead Generation
• Drug Development
• FHD Preparation
• Lead Optimization
• Phase IA
• Phase IB/2

Drug Discovery Informatics, Mode Outlook (Revenue - USD Million, 2019 - 2032)

• Outsourced
• In-house

Drug Discovery Informatics, Services Outlook (Revenue - USD Million, 2019 - 2032)

• Clinical Trial Data Management
• Docking
• Molecular Modeling
• Sequence Analysis Platforms
• Others

Drug Discovery Informatics, End User Outlook (Revenue - USD Million, 2019 - 2032)

• Biotechnology Companies
• Contract Research Organization (CROs)
• Pharmaceutical Companies
• Others

Drug Discovery Informatics, Regional Outlook (Revenue - USD Million, 2019 - 2032)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Australia
• Rest of APAC
• Latin America
• Argentina
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of MEA

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Drug Discovery Informatics Market Insights

• 4.1. Drug Discovery Informatics Market - Application Snapshot
• 4.2. Drug Discovery Informatics Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Significant growth strategies employed by industry players are driving the drug discovery informatics market growth
    • 4.2.1.2. Government initiatives for developing products for rare diseases are propelling the drug discovery informatics market size
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Inconsistent data quality is hindering the adoption of drug discovery informatics
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Drug Discovery Informatics Market Application Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Drug Discovery Informatics Market, by Application

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
• 5.3. Drug Discovery
  • 5.3.1. Global Drug Discovery Informatics Market, by Drug Discovery, by Region, 2019-2032 (USD Million)
  • 5.3.2. Identification, Validation, & Assay Development Informatics
    • 5.3.2.1. Global Drug Discovery Informatics Market, by Identification, Validation, & Assay Development Informatics, by Region, 2019-2032 (USD Million)
  • 5.3.3. Lead Generation
    • 5.3.3.1. Global Drug Discovery Informatics Market, by Lead Generation, by Region, 2019-2032 (USD Million)
• 5.4. Drug Development
  • 5.4.1. Global Drug Discovery Informatics Market, by Drug Development, by Region, 2019-2032 (USD Million)
  • 5.4.2. FHD Preparation
    • 5.4.2.1. Global Drug Discovery Informatics Market, by FHD Preparation, by Region, 2019-2032 (USD Million)
  • 5.4.3. Lead Optimization
    • 5.4.3.1. Global Drug Discovery Informatics Market, by Lead Optimization, by Region, 2019-2032 (USD Million)
  • 5.4.4. Phase IA
    • 5.4.4.1. Global Drug Discovery Informatics Market, by Phase IA, by Region, 2019-2032 (USD Million)
  • 5.4.5. Phase IB/2
    • 5.4.5.1. Global Drug Discovery Informatics Market, by Phase IB/2, by Region, 2019-2032 (USD Million)

6. Global Drug Discovery Informatics Market, by Mode

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
• 6.3. Outsourced
  • 6.3.1. Global Drug Discovery Informatics Market, by Outsourced, by Region, 2019-2032 (USD Million)
• 6.4. In-house
  • 6.4.1. Global Drug Discovery Informatics Market, by In-house, by Region, 2019-2032 (USD Million)

7. Global Drug Discovery Informatics Market, by Services

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
• 7.3. Clinical Trial Data Management
  • 7.3.1. Global Drug Discovery Informatics Market, by Clinical Trial Data Management, by Region, 2019-2032 (USD Million)
• 7.4. Docking
  • 7.4.1. Global Drug Discovery Informatics Market, by Docking, by Region, 2019-2032 (USD Million)
• 7.5. Molecular Modeling
  • 7.5.1. Global Drug Discovery Informatics Market, by Molecular Modeling, by Region, 2019-2032 (USD Million)
• 7.6. Sequence Analysis Platforms
  • 7.6.1. Global Drug Discovery Informatics Market, by Sequence Analysis Platforms, by Region, 2019-2032 (USD Million)
• 7.7. Others
  • 7.7.1. Global Drug Discovery Informatics Market, by Others, by Region, 2019-2032 (USD Million)

8. Global Drug Discovery Informatics Market, by End User

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• 8.3. Biotechnology Companies
  • 8.3.1. Global Drug Discovery Informatics Market, by Biotechnology Companies, by Region, 2019-2032 (USD Million)
• 8.4. Contract Research Organization (CROs)
  • 8.4.1. Global Drug Discovery Informatics Market, by Contract Research Organization (CROs), by Region, 2019-2032 (USD Million)
• 8.5. Pharmaceutical Companies
  • 8.5.1. Global Drug Discovery Informatics Market, by Pharmaceutical Companies, by Region, 2019-2032 (USD Million)
• 8.6. Others
  • 8.6.1. Global Drug Discovery Informatics Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Drug Discovery Informatics Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Drug Discovery Informatics Market Assessment, By Geography, 2019-2032 (USD Million)
• 9.3. Drug Discovery Informatics Market - North America
  • 9.3.1. North America: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  • 9.3.2. North America: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  • 9.3.3. North America: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  • 9.3.4. North America: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.3.5. Drug Discovery Informatics Market - U.S.
    • 9.3.5.1. U.S.: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.3.5.2. U.S.: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.3.5.3. U.S.: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.3.5.4. U.S.: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.3.6. Drug Discovery Informatics Market - Canada
    • 9.3.6.1. Canada: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.3.6.2. Canada: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.3.6.3. Canada: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.3.6.4. Canada: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• 9.4. Drug Discovery Informatics Market - Europe
  • 9.4.1. Europe: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  • 9.4.2. Europe: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  • 9.4.3. Europe: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  • 9.4.4. Europe: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.4.5. Drug Discovery Informatics Market - UK
    • 9.4.5.1. UK: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.4.5.2. UK: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.4.5.3. UK: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.4.5.4. UK: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.4.6. Drug Discovery Informatics Market - France
    • 9.4.6.1. France: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.4.6.2. France: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.4.6.3. France: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.4.6.4. France: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.4.7. Drug Discovery Informatics Market - Germany
    • 9.4.7.1. Germany: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.4.7.2. Germany: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.4.7.3. Germany: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.4.7.4. Germany: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.4.8. Drug Discovery Informatics Market - Italy
    • 9.4.8.1. Italy: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.4.8.2. Italy: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.4.8.3. Italy: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.4.8.4. Italy: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.4.9. Drug Discovery Informatics Market - Spain
    • 9.4.9.1. Spain: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.4.9.2. Spain: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.4.9.3. Spain: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.4.9.4. Spain: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.4.10. Drug Discovery Informatics Market - Netherlands
    • 9.4.10.1. Netherlands: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.4.10.2. Netherlands: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.4.10.3. Netherlands: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.4.10.4. Netherlands: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.4.11. Drug Discovery Informatics Market - Russia
    • 9.4.11.1. Russia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.4.11.2. Russia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.4.11.3. Russia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.4.11.4. Russia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.4.12. Drug Discovery Informatics Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.4.12.2. Rest of Europe: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.4.12.3. Rest of Europe: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.4.12.4. Rest of Europe: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• 9.5. Drug Discovery Informatics Market - Asia Pacific
  • 9.5.1. Asia Pacific: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  • 9.5.2. Asia Pacific: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  • 9.5.3. Asia Pacific: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  • 9.5.4. Asia Pacific: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.5.5. Drug Discovery Informatics Market - China
    • 9.5.5.1. China: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.5.5.2. China: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.5.5.3. China: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.5.5.4. China: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.5.6. Drug Discovery Informatics Market - India
    • 9.5.6.1. India: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.5.6.2. India: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.5.6.3. India: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.5.6.4. India: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.5.7. Drug Discovery Informatics Market - Malaysia
    • 9.5.7.1. Malaysia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.5.7.2. Malaysia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.5.7.3. Malaysia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.5.7.4. Malaysia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.5.8. Drug Discovery Informatics Market - Japan
    • 9.5.8.1. Japan: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.5.8.2. Japan: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.5.8.3. Japan: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.5.8.4. Japan: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.5.9. Drug Discovery Informatics Market - Indonesia
    • 9.5.9.1. Indonesia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.5.9.2. Indonesia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.5.9.3. Indonesia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.5.9.4. Indonesia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.5.10. Drug Discovery Informatics Market - South Korea
    • 9.5.10.1. South Korea: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.5.10.2. South Korea: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.5.10.3. South Korea: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.5.10.4. South Korea: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.5.11. Drug Discovery Informatics Market - Australia
    • 9.5.11.1. Australia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.5.11.2. Australia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.5.11.3. Australia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.5.11.4. Australia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.5.12. Drug Discovery Informatics Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.5.12.2. Rest of Asia Pacific: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.5.12.3. Rest of Asia Pacific: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.5.12.4. Rest of Asia Pacific: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• 9.6. Drug Discovery Informatics Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  • 9.6.2. Middle East & Africa: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  • 9.6.3. Middle East & Africa: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  • 9.6.4. Middle East & Africa: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.6.5. Drug Discovery Informatics Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.6.5.2. Saudi Arabia: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.6.5.3. Saudi Arabia: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.6.5.4. Saudi Arabia: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.6.6. Drug Discovery Informatics Market - UAE
    • 9.6.6.1. UAE: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.6.6.2. UAE: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.6.6.3. UAE: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.6.6.4. UAE: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.6.7. Drug Discovery Informatics Market - Israel
    • 9.6.7.1. Israel: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.6.7.2. Israel: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.6.7.3. Israel: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.6.7.4. Israel: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.6.8. Drug Discovery Informatics Market - South Africa
    • 9.6.8.1. South Africa: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.6.8.2. South Africa: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.6.8.3. South Africa: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.6.8.4. South Africa: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.6.9. Drug Discovery Informatics Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.6.9.2. Rest of Middle East & Africa: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.6.9.3. Rest of Middle East & Africa: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.6.9.4. Rest of Middle East & Africa: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
• 9.7. Drug Discovery Informatics Market - Latin America
  • 9.7.1. Latin America: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
  • 9.7.2. Latin America: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
  • 9.7.3. Latin America: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
  • 9.7.4. Latin America: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.7.5. Drug Discovery Informatics Market - Mexico
    • 9.7.5.1. Mexico: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.7.5.2. Mexico: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.7.5.3. Mexico: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.7.5.4. Mexico: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.7.6. Drug Discovery Informatics Market - Brazil
    • 9.7.6.1. Brazil: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.7.6.2. Brazil: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.7.6.3. Brazil: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.7.6.4. Brazil: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.7.7. Drug Discovery Informatics Market - Argentina
    • 9.7.7.1. Argentina: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.7.7.2. Argentina: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.7.7.3. Argentina: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.7.7.4. Argentina: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)
  • 9.7.8. Drug Discovery Informatics Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Drug Discovery Informatics Market, by Application, 2019-2032 (USD Million)
    • 9.7.8.2. Rest of Latin America: Drug Discovery Informatics Market, by Mode, 2019-2032 (USD Million)
    • 9.7.8.3. Rest of Latin America: Drug Discovery Informatics Market, by Services, 2019-2032 (USD Million)
    • 9.7.8.4. Rest of Latin America: Drug Discovery Informatics Market, by End User, 2019-2032 (USD Million)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Accenture
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Agilent Technologies, Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Boehringer Ingelheim International GmbH
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Certara
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Charles River Laboratories
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. Chemaxon Ltd.
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Collaborative Drug Discovery Inc.
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Eurofins DiscoverX Products
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Illumina, Inc.
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Infosys Limited
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Jubilant Biosys Ltd.
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development
• 11.12. Oracle
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Benchmarking
  • 11.12.4. Recent Development
• 11.13. QIAGEN
  • 11.13.1. Company Overview
  • 11.13.2. Financial Performance
  • 11.13.3. Product Benchmarking
  • 11.13.4. Recent Development
• 11.14. Sapio Sciences
  • 11.14.1. Company Overview
  • 11.14.2. Financial Performance
  • 11.14.3. Product Benchmarking
  • 11.14.4. Recent Development
• 11.15. Selvita
  • 11.15.1. Company Overview
  • 11.15.2. Financial Performance
  • 11.15.3. Product Benchmarking
  • 11.15.4. Recent Development